Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at Jefferies

May 1, 2026 3:12 PM

Jefferies analyst Faisal Khurshid lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $37.00 (from $40.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found